Changes in the level of tyrosinase expression in the retinal pigment epithelium during the development of experimental optic nerve degeneration
- Authors: Barieva A.M.1,2, Valiullin V.V.1, Samoilov A.N.1,2
-
Affiliations:
- Kazan State Medical University
- Republican Clinical Ophthalmological Hospital
- Issue: Vol 105, No 3 (2024)
- Pages: 452-458
- Section: Experimental medicine
- Submitted: 20.07.2023
- Accepted: 27.04.2024
- Published: 03.06.2024
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/562752
- DOI: https://doi.org/10.17816/KMJ562752
- ID: 562752
Cite item
Abstract
BACKGROUND: With optic nerve degeneration of various origins, retinal neurons are the most vulnerable, and their state under these conditions has been studied in sufficient detail. At the same time, the retinal pigment epithelium plays a very important role, realizing the synthesis of melanin and performing antioxidant, phagocytic, transport, protective, and homeostatic functions. Tyrosinase serves as a key enzyme in melanogenesis by cells of this epithelium. The development of methods for early diagnosis of optic nerve atrophy is extremely important due to the fact that functional visual impairments appear later than structural ones, at more advanced stages of the disease. The retinal pigment epithelium cannot be insensitive to the processes that occur during optic nerve degeneration. That is why its study in experimental degeneration of the optic nerve is necessary for a more complete understanding of the processes occurring in the visual analyzer under these conditions.
AIM: To study changes in the level of tyrosinase expression in the retinal pigment epithelium at different development stages of experimental optic nerve degeneration based on morphological data.
MATERIAL AND METHODS: The subjects of the study were 40 rat eyes after creating a model of optic nerve atrophy using methanol. The animals were divided into five groups: the first group — control; the second to fifth groups included animals whose eyes were enucleated 1, 3, 6 and 9 weeks after the creation of the aminophylline-methanol model of optic nerve atrophy, respectively. The retinal pigment epithelium was studied using fluorescent antibodies to tyrosinase Tyrosinase Mouse Monoclonal. Immunofluorescence staining was performed on fixed transverse sections of the eyeball. Statistical analysis and visualization of the obtained data were carried out using the environment for statistical computing R 4.2.2.
RESULTS: A comparative analysis of the results obtained revealed that the level of tyrosinase expression in the fifth group was on average 4.21 times [95% confidence interval (CI) 2.49–7.13, p=0.00076], 9.31 times (95% CI 5.47–15.85, p=0.00033), 2.63 times (95% CI 1.51–4.58, p=0.0009) and 3.44 times (95% CI 1.96–6.03, p=0.00055) higher compared to the first, second, third and fourth groups, respectively. The level of tyrosinase in experimental samples in the first, third and fourth groups was statistically higher compared to the level of tyrosinase in the second group by an average of 2.21 times (95% CI 1.33–3.66, p=0.0003), 3.53 times (95% CI 2.08–6.02, p=0.00069) and 2.71 times (95% CI 1.58–4.65, p=0.00022), respectively.
CONCLUSION: As degenerative processes develop in the optic nerve fibers under these conditions, the integrity of the retinal pigment epithelium is disrupted, which is characterized by an increase in antibodies to tyrosinase in the retinal pigment epithelium of experimental animals.
Full Text
About the authors
Aigul M. Barieva
Kazan State Medical University; Republican Clinical Ophthalmological Hospital
Author for correspondence.
Email: rezaig@mail.ru
ORCID iD: 0000-0001-9009-1273
SPIN-code: 2781-5770
Assistant, Depart. of Ophthalmology; Ophthalmologist
Russian Federation, Kazan; KazanViktor V. Valiullin
Kazan State Medical University
Email: valiullinvv@yandex.ru
ORCID iD: 0000-0002-0299-696X
SPIN-code: 7170-4257
Dr. Sci. (Biol.), Prof., Depart. of Histology, Cytology and Embryology
Russian Federation, KazanAlexander N. Samoilov
Kazan State Medical University; Republican Clinical Ophthalmological Hospital
Email: samoilovan16@gmail.com
ORCID iD: 0000-0003-0863-7762
SPIN-code: 8555-2067
M.D., Dr. Sci. (Med.), Prof., Head of Depart., Depart. of Ophthalmology; Chief Specialist
Russian Federation, Kazan; KazanReferences
- Biousse V, Newman NJ. Diagnosis and clinical features of common optic neuropathies. Lancet Neurol. 2016;15(13):1355–1367. doi: 10.1016/S1474-4422(16)30237-X
- Mackay DD, Garza PS, Bruce BB, Newman NJ, Biousse V. The demise of direct ophthalmoscopy: A modern clinical challenge. Neurol Clin Pract. 2015;5(2):150–157. doi: 10.1212/CPJ.0000000000000115
- Drexler W, Morgner U, Ghanta RK, Kärtner FX, Schuman JS, Fujimoto JG. Ultrahighresolution ophthalmic optical coherence tomography. Nat Med. 2001;7(4):502–507. doi: 10.1038/86589
- Fayzrakhmanov RR, Bosov ED, Bogdanova VA, Vaganova EE, Sekhina OL. Morphofunctional retinal pigment epithelium changes in normal eye and age-related macular degeneration. Ophthalmosurgery. 2023;(3):106–111. (In Russ.) doi: 10.25276/0235-4160-2023-3-106-111
- Marmor MF, Wolfensberger TJ. The retinal pigment epithelium: Function and disease. New York: Oxford University Press; 1998. р. 103–134.
- Parapuram SK, Chang B, Li L, Hartung RA, Chalam KV, Nair-Menon JU, Hunt DM, Hunt RC. Differential effects of TGFbeta and vitreous on the transformation of retinal pigment epithelial cells. Invest Ophthalmol Vis Sci. 2009;50(12):5965–5974. doi: 10.1167/iovs.09-3621
- Nordstrem B. Bioelectric circuits of the body. Vestnik biofizicheskoi meditsiny. 1996;(1):27–31. (In Russ.)
- Trip SA, Schlottmann PG, Jones SJ, Li WY, Garway-Heath DF, Thompson AJ, Plant GT, Miller DH. Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage. 2006;31(1):286–293. doi: 10.1016/j.neuroimage.2005.11.051
- Carlson BM. Regeneratsiya. (Regeneration.) Moscow: Nauka, 1986. 296 р. (In Russ.)
- Dudel J, Ruegt I, Schmidt R. Fiziologiya cheloveka. V 4 tomakh. Per. s angl. (Human physiology. In 4 vol. Trans. from English.) Vol. 1. Moscow: Mir, 1985. 272 р. (In Russ.)
- Mulder M. Vvedenie v membrannuyu tekhnologiyu. Per. s angl. (Introduction to membrane technology. Trans. from English.) M.: Mir, 1999. 513 р. (In Russ.)
- Samoilov AN, Valiullin VV, Barieva AM, et al. Sposob sozdaniya toksicheskoi modeli atrofii zritel'nogo nerva. (A method for creating a toxic model of optic nerve atrophy.) Patent No. RU 2786324 C1. MPK G09B 23/28. Bull. No. 35 from 20.12.2022. (In Russ.)
- Men'shikova MV, Dolgikh OV, Agafonov YuV, Zashikhin AL. Tsitologiya. Uchebnoe posobie k prakticheskim zanyatiyam. (Cytology. A manual for practical exercises.) Arkhangel'sk: Izd-vo Severnogo gosudarstvennogo meditsinskogo universiteta, 2016. 136 р. (In Russ.)
- Barban PS, Pshenichnov RA, Pantyukhina AN, Ivshina IB. Immunofluorestsentnyi analiz. (Immunofluorescence analysis.) Sverdlovsk: UrO AN SSSR, 1988. 176 р. (In Russ.)
- Testa F, Maguire AM, Rossi S, Pierce EA, Melillo P, Marshall K, Banfi S, Surace EM, Sun J, Acerra C, Wright JF, Wellman J, High KA, Auricchio A, Bennett J, Simonelli F. Three-year follow-up after unilateral subretinal delivery of adeno-associated virus in patients with Leber congenital Amaurosis type 2. Ophthalmology. 2013;120(6):1283–1291. doi: 10.1016/j.ophtha.2012.11.048